专业概况
在这里学什么？
COVID - 19 Update: We will begin transitioning to virtual instruction for graduate and undergraduate classes.
Harvard offers a joint degree program that confers an MBA from Harvard Business School and a Master of Science from the Graduate School of Arts and Sciences and Harvard Medical School in the Harvard Department of Stem Cell and Regenerative Biology, a Faculty of Arts and Sciences/Harvard Medical School joint department. The program is completed over two academic years, utilizing January terms and time in August at the start of the program.
Upon completion of the program, graduates will be able to:
- Assess the potential therapeutic value of discoveries emanating from lab-discovery in the life sciences and understand ways to accelerate these discoveries into therapeutics.
- Lead science-based organizations, including businesses and non-profits, with an understanding of research culture, relevant timeframes, opportunity-costs, rewards, and organizational behavior.
- Determine the most promising strategy for science-based organizations, including novel ways for expanding access to transformative therapies.
- Understand the financial underpinnings of investment decisions in the life sciences, including real-option approaches to investments, as well as the role of scientific, commercial, policy, and regulatory uncertainties in affecting these opportunities.
- Develop approaches to ethical dilemmas bedeviling novel therapeutics, including investment in neglected diseases, the provision of life-saving drugs to disadvantaged patients and those in the developing world, and the pricing of medicines.
所属院系
进入哪个院系学习？ Harvard Business School
中国学生入学要求
课程信息
学制：在线/远程学习(2 年)
学费：US$84,455.00 (¥ 537,294) /年
开学时间：预计在五月 2022
申请截止日期：
留学地点：
院校相关阅读
- · 美国哈佛大学本科录取免SAT/ACT成绩政策将延续至2026年！
